Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor
- Resource Type
- Article
- Source
- In
Acta Pharmaceutica Sinica B January 2022 - Subject
- Language
- ISSN
- 2211-3835